Australian-founded medical technology company SYMBYX today announced compelling results from a 72-week randomized controlled ...
While there’s no cure, there are some ways to put the brakes on this progressive disease. First: exercise! People with early ...
In this video, Andres Deik, MD, MSEd, FAAN, discusses the results of the CYCLE-II trial, presented at the 2025 International Congress of Parkinson’s Disease and Movement Disorders.
The drug will now progress to pivotal Phase III trials after demonstrating trends towards a disease-modifying impact.
Parkinson’s disease currently affects nearly one million Americans with no specific known cause and no cure. Treatments have ...
Parkinson’s is the fastest-growing neurodegenerative condition in the world, and the Coachella Valley is uniquely affected ...
In today's Daily Briefing, we tell you about local programs using innovative therapies for Parkinson's patients, why the city ...
Readers, many with Parkinson’s, respond to an article about Sue Goldie, who has the disease. Also: Tears over Trump’s America ...
Degradation studies indicated that about 82% of the implants disintegrated within seven days. Complete degradation of the ...
Research on Parkinson’s is revealing several risk factors related to our lifestyles and environment, and you can act on some ...
The cell therapy field has long held a transformative ambition: to create "off-the-shelf" treatments that can reach not just ...